This special series on Cardiovascular Precision Medicine is edited by Dr. Sridevi Devaraj, Department of Clinical Chemistry and POCT, Texas Children’s Microbiome Center, Texas Children's Hospital, Houston, TX, USA; and Dr. Jing Cao, from Clinical Chemistry, Texas Children's Hospital; Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
Review Article
Atherogenic postprandial remnant lipoproteins—a causal lipoproteins for the initiation of obesity and atherosclerosis
Impact of trimethylamine N-oxide (TMAO) metaorganismal pathway on cardiovascular disease
GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment
Pharmacogenomics in cardiovascular precision medicine
Lifetime risks factors and assessment of cardiovascular disease
Disclosure:
The series “Cardiovascular Precision Medicine” was commissioned by the editorial office, Journal of Laboratory and Precision Medicine without any sponsorship or funding. Sridevi Devaraj and Jing Cao served as the unpaid Guest Editors for the series.